• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病动物模型:弥合疾病特征与研究问题之间的差距。

Animal models of Parkinson's disease: bridging the gap between disease hallmarks and research questions.

机构信息

CERVO Brain Research Centre, 2601, Chemin de la Canardière, Québec, QC, G1J 2G3, Canada.

Department of Psychiatry and Neurosciences, Faculty of Medicine, Université Laval, Québec, QC, Canada.

出版信息

Transl Neurodegener. 2023 Jul 19;12(1):36. doi: 10.1186/s40035-023-00368-8.

DOI:10.1186/s40035-023-00368-8
PMID:37468944
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10354932/
Abstract

Parkinson's disease (PD) is a progressive neurodegenerative disorder characterized by motor and non-motor symptoms. More than 200 years after its first clinical description, PD remains a serious affliction that affects a growing proportion of the population. Prevailing treatments only alleviate symptoms; there is still neither a cure that targets the neurodegenerative processes nor therapies that modify the course of the disease. Over the past decades, several animal models have been developed to study PD. Although no model precisely recapitulates the pathology, they still provide valuable information that contributes to our understanding of the disease and the limitations of our treatment options. This review comprehensively summarizes the different animal models available for Parkinson's research, with a focus on those induced by drugs, neurotoxins, pesticides, genetic alterations, α-synuclein inoculation, and viral vector injections. We highlight their characteristics and ability to reproduce PD-like phenotypes. It is essential to realize that the strengths and weaknesses of each model and the induction technique at our disposal are determined by the research question being asked. Our review, therefore, seeks to better aid researchers by ensuring a concrete discernment of classical and novel animal models in PD research.

摘要

帕金森病(PD)是一种进行性神经退行性疾病,其特征为运动和非运动症状。在首次临床描述 200 多年后,PD 仍然是一种严重的疾病,影响着越来越多的人群。目前的治疗方法只能缓解症状;既没有针对神经退行性过程的治疗方法,也没有可以改变疾病进程的疗法。在过去几十年中,已经开发出了几种动物模型来研究 PD。尽管没有一种模型能完全重现病理,但它们仍提供了有价值的信息,有助于我们了解疾病和治疗选择的局限性。这篇综述全面总结了用于帕金森研究的不同动物模型,重点介绍了那些由药物、神经毒素、农药、遗传改变、α-突触核蛋白接种和病毒载体注射诱导的模型。我们强调了它们的特点和重现 PD 样表型的能力。必须认识到,每个模型的优缺点以及我们可利用的诱导技术取决于所提出的研究问题。因此,我们的综述旨在通过确保对 PD 研究中的经典和新型动物模型进行具体的辨别,来更好地帮助研究人员。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ac3/10354932/4c054370efb4/40035_2023_368_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ac3/10354932/ffdebb44da50/40035_2023_368_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ac3/10354932/4c054370efb4/40035_2023_368_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ac3/10354932/ffdebb44da50/40035_2023_368_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ac3/10354932/4c054370efb4/40035_2023_368_Fig2_HTML.jpg

相似文献

1
Animal models of Parkinson's disease: bridging the gap between disease hallmarks and research questions.帕金森病动物模型:弥合疾病特征与研究问题之间的差距。
Transl Neurodegener. 2023 Jul 19;12(1):36. doi: 10.1186/s40035-023-00368-8.
2
Animal Models for Parkinson's Disease Research: Trends in the 2000s.帕金森病研究的动物模型:21 世纪的趋势。
Int J Mol Sci. 2019 Oct 30;20(21):5402. doi: 10.3390/ijms20215402.
3
How can rAAV-α-synuclein and the fibril α-synuclein models advance our understanding of Parkinson's disease?重组腺相关病毒-α-突触核蛋白和丝状α-突触核蛋白模型如何促进我们对帕金森病的理解?
J Neurochem. 2016 Oct;139 Suppl 1(Suppl 1):131-155. doi: 10.1111/jnc.13627. Epub 2016 May 4.
4
Classic and evolving animal models in Parkinson's disease.帕金森病的经典和演进动物模型。
Pharmacol Biochem Behav. 2020 Dec;199:173060. doi: 10.1016/j.pbb.2020.173060. Epub 2020 Oct 19.
5
Modelling Parkinson's Disease in : Strengths and Limitations.帕金森病模型研究:优势与局限。
Curr Pharm Des. 2022;28(37):3033-3048. doi: 10.2174/1381612828666220915103502.
6
New Developments in Genetic rat models of Parkinson's Disease.帕金森病基因大鼠模型的新进展。
Mov Disord. 2018 May;33(5):717-729. doi: 10.1002/mds.27296. Epub 2018 Feb 8.
7
Back and to the Future: From Neurotoxin-Induced to Human Parkinson's Disease Models.《回到未来:从神经毒素诱导的帕金森病模型到人类帕金森病模型》
Curr Protoc Neurosci. 2020 Mar;91(1):e88. doi: 10.1002/cpns.88.
8
A53T-α-synuclein overexpression in murine locus coeruleus induces Parkinson's disease-like pathology in neurons and glia.A53T-α-突触核蛋白在小鼠蓝斑中的过表达诱导神经元和神经胶质细胞出现类似帕金森病的病变。
Acta Neuropathol Commun. 2018 May 10;6(1):39. doi: 10.1186/s40478-018-0541-1.
9
Animal models of the non-motor features of Parkinson's disease.帕金森病非运动症状的动物模型。
Neurobiol Dis. 2012 Jun;46(3):597-606. doi: 10.1016/j.nbd.2011.12.040. Epub 2012 Jan 3.
10
Pre-clinical Aspects and Contemporary Treatments of Parkinson's Disease.帕金森病的临床前研究现状与当代治疗策略
CNS Neurol Disord Drug Targets. 2024;23(8):996-1014. doi: 10.2174/0118715273258646230920074421.

引用本文的文献

1
Apolipoprotein A (ApoA) in Neurological Disorders: Connections and Insights.载脂蛋白A(ApoA)在神经系统疾病中的关联与见解
Int J Mol Sci. 2025 Aug 16;26(16):7908. doi: 10.3390/ijms26167908.
2
Integrating artificial intelligence and optogenetics for Parkinson's disease diagnosis and therapeutics in male mice.整合人工智能与光遗传学用于雄性小鼠帕金森病的诊断与治疗
Nat Commun. 2025 Aug 21;16(1):7797. doi: 10.1038/s41467-025-63025-w.
3
Garlic-Derived Allicin Attenuates Parkinson's Disease via PKA/p-CREB/BDNF/DAT Pathway Activation and Apoptotic Inhibition.

本文引用的文献

1
The Absence of Parkin Does Not Promote Dopamine or Mitochondrial Dysfunction in PolgA Mitochondrial Mutator Mice.Parkin 的缺失并不会促进 PolgA 线粒体突变小鼠中的多巴胺或线粒体功能障碍。
J Neurosci. 2022 Dec 7;42(49):9263-9277. doi: 10.1523/JNEUROSCI.0545-22.2022. Epub 2022 Oct 24.
2
Neuromelanin in Parkinson's Disease: Tyrosine Hydroxylase and Tyrosinase.帕金森病中的神经黑色素:酪氨酸羟化酶和酪氨酸酶。
Int J Mol Sci. 2022 Apr 10;23(8):4176. doi: 10.3390/ijms23084176.
3
A light-inducible protein clustering system for in vivo analysis of α-synuclein aggregation in Parkinson disease.
大蒜衍生的蒜素通过激活PKA/p-CREB/BDNF/DAT通路和抑制凋亡来减轻帕金森病。
Molecules. 2025 Aug 4;30(15):3265. doi: 10.3390/molecules30153265.
4
Parkinson's Disease: Bridging Gaps, Building Biomarkers, and Reimagining Clinical Translation.帕金森病:弥合差距、构建生物标志物及重塑临床转化
Cells. 2025 Jul 28;14(15):1161. doi: 10.3390/cells14151161.
5
Understanding the Pre-Clinical Stages of Parkinson's Disease: Where Are We in Clinical and Research Settings?了解帕金森病的临床前期阶段:我们在临床和研究方面进展如何?
Int J Mol Sci. 2025 Jul 17;26(14):6881. doi: 10.3390/ijms26146881.
6
C18:0 GM3 ganglioside's efficacy in LPS-induced parkinsonism: neuroprotection, inflammatory inhibition and gliosis mitigation.C18:0 GM3神经节苷脂在脂多糖诱导的帕金森症中的功效:神经保护、炎症抑制和神经胶质增生缓解
Behav Brain Funct. 2025 Jul 26;21(1):25. doi: 10.1186/s12993-025-00289-8.
7
Neuroprotection in Parkinson Disease.帕金森病中的神经保护
Neurol Ther. 2025 Jul 18. doi: 10.1007/s40120-025-00793-z.
8
Histone deacetylase 6: A new player in oxidative stress‑associated disorders and cancers (Review).组蛋白去乙酰化酶6:氧化应激相关疾病和癌症中的新角色(综述)
Int J Mol Med. 2025 Sep;56(3). doi: 10.3892/ijmm.2025.5578. Epub 2025 Jul 11.
9
Dynamic Changes in Oxidative Stress and Epigenetic Modifications in the Ventral Mesencephalon and Striatum of MPTP-Treated Mice: Implications for Parkinson's Disease Pathogenesis.MPTP 处理小鼠中脑腹侧和纹状体氧化应激与表观遗传修饰的动态变化:对帕金森病发病机制的启示
Neurotox Res. 2025 Jul 4;43(4):30. doi: 10.1007/s12640-025-00748-0.
10
Advances, challenges, and opportunities of human midbrain organoids for modelling of the dopaminergic system.用于多巴胺能系统建模的人类中脑类器官的进展、挑战与机遇
EMBO J. 2025 Jul 2. doi: 10.1038/s44318-025-00494-1.
一种光诱导的蛋白质聚集系统,用于帕金森病中α-突触核蛋白聚集的体内分析。
PLoS Biol. 2022 Mar 9;20(3):e3001578. doi: 10.1371/journal.pbio.3001578. eCollection 2022 Mar.
4
Animal models of Parkinson's disease: a guide to selecting the optimal model for your research.帕金森病动物模型:为您的研究选择最佳模型指南
Neuronal Signal. 2021 Dec 8;5(4):NS20210026. doi: 10.1042/NS20210026. eCollection 2021 Dec.
5
Rapid Induction of Dopaminergic Neuron Loss Accompanied by Lewy Body-Like Inclusions in A53T BAC-SNCA Transgenic Mice.A53T BAC-SNCA 转基因小鼠中伴随着路易小体样包涵体的多巴胺能神经元快速丧失。
Neurotherapeutics. 2022 Jan;19(1):289-304. doi: 10.1007/s13311-021-01169-5. Epub 2021 Dec 21.
6
Assembly of α-synuclein and neurodegeneration in the central nervous system of heterozygous M83 mice following the peripheral administration of α-synuclein seeds.α-突触核蛋白在杂合 M83 小鼠中枢神经系统中的组装和神经退行性变,以及外周给予α-突触核蛋白种子后的变化。
Acta Neuropathol Commun. 2021 Nov 24;9(1):189. doi: 10.1186/s40478-021-01291-7.
7
Disruption of mitochondrial complex I induces progressive parkinsonism.线粒体复合物 I 的破坏会导致进行性帕金森病。
Nature. 2021 Nov;599(7886):650-656. doi: 10.1038/s41586-021-04059-0. Epub 2021 Nov 3.
8
Mitochondrial Dysfunction, Protein Misfolding and Neuroinflammation in Parkinson's Disease: Roads to Biomarker Discovery.线粒体功能障碍、蛋白质错误折叠与神经炎症在帕金森病中的作用:生物标志物发现之路。
Biomolecules. 2021 Oct 13;11(10):1508. doi: 10.3390/biom11101508.
9
Lipopolysaccharide animal models of Parkinson's disease: Recent progress and relevance to clinical disease.帕金森病的脂多糖动物模型:最新进展及其与临床疾病的相关性
Brain Behav Immun Health. 2020 Mar 18;4:100060. doi: 10.1016/j.bbih.2020.100060. eCollection 2020 Apr.
10
A Summary of Phenotypes Observed in the In Vivo Rodent Alpha-Synuclein Preformed Fibril Model.在体内鼠源α-突触核蛋白原纤维模型中观察到的表型概述。
J Parkinsons Dis. 2021;11(4):1555-1567. doi: 10.3233/JPD-212847.